| Category: |
Antibody |
| Concentration: |
pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
BPI |
| Host animal: |
Goat (Capra aegagrus hircus) |
| Clonality: |
Polyclonal (goat origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
ELISA (peptide), WB |
| Recommended dilutions: |
3-1ug/ml, ELISA (peptide) LOD: 1:128000, Western blot: 0 |
| Notes: |
Optimal dilution of the BPI antibody should be determined by the researcher |
| Intented use: |
This BPI antibodyis to be used only for research purposes and not for diagnostics |
| Gene ID #: |
671 |
| Purity: |
Antigen affinity |
| Description: |
Additional name(s) for this target protein: Bactericidal permeability-increasing protein |
| Immunogen: |
Amino acids KIPDYSDSFKIKH were used as the immunogen for this BPI antibody |
| Storage: |
Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the BPI antibody at -20 deg |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
BPI |
| Short name: |
BPI Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
bactericidal/permeability-increasing protein (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BPI and IDBG-642592 and ENSBTAG00000014046 and 280734, BPI and IDBG-74654 and ENSG00000101425 and 149684, BPIFD1 and rBPI, Bpi and IDBG-211473 and ENSMUSG00000052922 and 329547, Plasma membranes, lipid binding, this GO :0001530 and lipopolysaccharide binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006955 and immune response and biological process this GO :0008289 and lipid binding and molecular function this GO :0032715 and negative regulation of interleukin-6 production and biological process this GO :0032717 and negative regulation of interleukin-8 production and biological process this GO :0032720 and negative regulation of tumor necrosis factor production and biological process this GO :0042742 and defense response to bacterium and biological process this GO :0043031 and negative regulation of macrophage activation and biological process this GO :0045087 and innate immune response and biological process this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0001530 : lipopolysaccharide binding, this GO :0001530 : lipopolysaccharide binding and also this GO :0008289 : lipid binding, this GO :0008289 : lipid binding, 671, bactericidal/permeability-increasing protein |
| Identity: |
1095 |
| Gene: |
BPI |
More about : BPI |
| Long gene name: |
bactericidal/permeability-increasing protein |
| Synonyms: |
BPIFD1 |
| Synonyms name: |
BPI fold containing family D, member 1 |
| Locus: |
20q11, 23 |
| Discovery year: |
1992-03-13 |
| GenBank acession: |
J04739 |
| Entrez gene record: |
671 |
| Pubmed identfication: |
8432532 |
| RefSeq identity: |
NM_001725 |
| Classification: |
BPI fold containing |
| Havana BLAST/BLAT: |
OTTHUMG00000032441 |